The gene encoding bacteriophage T7 RNA polymerase (T7genel) was placed under the control of regulatory elements from the Escherichia coli lac operon to construct an inducible vaccinia virus expression system consisting entirely of prokaryotic transcriptional machinery. Regulated expression of T7 RNA polymerase was necessary to construct a stable recombinant vaccinia virus harboring a T7 promoter; otherwise, uncontrolled expression led to interference with endogenous virus replication. To this end, the gene encoding the repressor protein of the lac operon was fused to a viral early/late promoter so that it was expressed constitutively, and the lac operator was interposed between a viral major late promoter and T7genel. Greater than 99% repression of T7 RNA polymerase, which was relieved approximately 80-fold in the presence of the inducer isopropyl-13-D-thiogalactopyranoside (IPTG), was obtained. An expression cassette containing a T7 promotercontrolled 1-galactosidase reporter gene was recombined into a different region of the viral genome containing T7genel. A stable, double recombinant virus was isolated and grown to a high titer. In the absence of inducer, P-galactosidase expression was substantially repressed. Addition of increasing amounts of IPTG induced expression of 13-galactosidase to the point of suppression of viral replication. This hybrid vaccinia virus system (Vac/Op/T7) has potential applications for the efficient bioproduction of a wide variety of gene products.
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Transcriptional and regulatory elements from viral or eukaryotic sources have been used extensively for the production and characterization of recombinant proteins in mammalian cells (16) . These eukaryotic expression vectors typically carry genetic elements which confer drug resistance, the ability to replicate autonomously, and regulatory control to the target gene of interest. Although use of mammalian cells is essential in many instances for the synthesis of biologically active eukaryotic proteins, stable transformants are oftentimes difficult to construct and target proteins may be expressed at relatively low levels in comparison with their bacterial counterparts. Moreover, if tight regulation of transcription is required for the expression of specific protein sequences, regulated eukaryotic transcription systems such as the metallothionein promoter (2, 21) or the mouse mammary tumor virus promoter (17, 19) may not be suitable, since they are leaky under noninduced conditions and show rather modest levels of induction. On the other hand, promoters that are highly inducible, such as those responsive to glucocorticoid hormones (18) , require the presence of hormone receptors in the cell; thereby restricting the range of cell types that can be used. As an alternative approach, a wide host range mammalian cell expression system incorporating desirable and highly regulatable prokaryotic transcriptional elements might have important advantages. For instance, the high catalytic activity, inducibility, and promoter specificity of several prokaryotic transcription systems have been well characterized. Thus, a eukaryotic expression system incorporating favorable transcriptional components from bacteria may offer a highly * Corresponding author. specific and efficient method for the biosynthesis of mammalian cell-derived proteins.
In previous reports (12, 15) , we described a chimeric system that provides useful expression of recombinant pro- teins. This system, referred to as the hybrid Vac/T7 system, is based on coinfection of cultured cells with two recombinant vaccinia viruses: one recombinant virus provides constitutive expression of bacteriophage T7 RNA polymerase which transcribes a T7 promoter-controlled target gene in the second virus. Although the Vac/T7 system has been widely used, inherent limitations exist. While the requirement for two viruses may be advantageous under some circumstances (e.g., expression of toxic proteins), it adds to the expense and complicates the protocol. For instance, optimal levels of expression are dependent on cells being infected with similar amounts of each virus. In addition, differential rates of virus replication may limit the ability to establish a spreading infection at a low multiplicity of infection (MOI). Our attempts to simplify this two-virus vector system by making a single recombinant vaccinia virus containing both T7 RNA polymerase and T7 promoter elements have been unsuccessful, presumably because of interference with viral transcription and/or replication. If expression of T7 RNA polymerase couid be negatively regulated and induced upon command, a single-virus expression system may be feasible (24) .
Here we describe the development of a vaccinia virus expression system composed primarily of prokaryotic transcriptional elements. A preliminary description of this work has been reported previously (1) . The 1 . Schematic representation of the interaction of lac repressor, inducer, and operator to control the synthesis of T7 RNA polymerase and subsequent induction of the target gene (lacZ). The lac repressor was synthesized at early and late times after infection by using the vaccinia P7.5 promoter. The active repressor binds to the lac operator (lacO) positioned between the vaccinia late promoter (P11) and the gene encoding T7 RNA polymerase (T7genel). In the presence of inducer, the repressor is inactivated, and expression of T7 RNA polymerase is induced. T7 RNA polymerase initiates transcription from a T7 promoter (PT7) and stops at the T7 terminator (TT7)-Chimeric T7-initiated transcripts are synthesized at high levels. A 5' stem-loop sequence (5'hp) stabilizes the transcripts from degradation. The dominant selectable marker, gpt, allows positive selection and retention of the target gene sequences inserted into the HA locus.
RESULTS
Construction of hybrid vaccinia virus promoters to control the expression of T7 RNA polymerase. A strategy was adopted to construct a recombinant vaccinia virus that was capable of regulated expression of T7 RNA polymerase and that contained a T7 promoter-controlled target gene (Fig. 1) . We felt that regulation of T7 RNA polymerase expression was necessary, as previous attempts to construct a recombinant vaccinia virus containing both T7 RNA polymerase and a T7 promoter-controlled target gene were unsuccessful apparently because of the low viability of the double recombinant (12) . Since small amounts of T7 RNA polymerase can direct most of the resources of an E. coli cell toward expression of a specific target gene, we reasoned that a similar event was occurring, thereby impeding the ability of the recombinant virus to replicate. Therefore, we considered the use of components from the E. coli lactose operon coding for the lac repressor (lacI) and its cognate operator sequence (lacO) to regulate the T7 RNA polymerase. Our objective was to construct a recombinant vaccinia virus that constitutively expressed lacI and that contained an appropriately placed lac operator sequence strategically positioned between a vaccinia virus late promoter (P11) and the coding sequence for T7 RNA polymerase (T7genel). If stringent repression of T7 RNA polymerase was achieved, then stable insertion of a T7 promoter-controlled target gene could be maintained in a second location in the viral genome. Induction of T7 RNA polymerase expression would then result in significant T7 promoter-specific transcription initiation and target gene expression.
To regulate the expression of T7genel, we first modified an expression vector that contained a lacI gene under control of the vaccinia virus early/late P7.5 promoter to allow the insertion of secondary gene cassettes (placlm, Fig. 2A ). We chose the P7.5 promoter because it is transcriptionally active at early and late times after infection (29) placOl. The sequences of these oligonucleotides were 5'-TAGCATAGAAAAAAACAAAATGAAATTCTACTATATT-TTA-3' for BAl, 5'-CTATGCTATAAATAGAATTGTGAGCGCTCACAATFA-3' for BA5, 5'-GATCTAATTGTGAGCGCTCACAATTCTATT-7A-3' for BA6, and 5'-TCGATAAAAATATAGTAGAAT-1TCATTTTGITT-1-1-1-1-1-1-3' for TF64. Plasmid pT7lacOI was constructed by cleaving placOl with PstI and BglII and inserting a 2.7-kbp PstI-BglII fragment containing T7genel from pTF7genel in which the Shine-Dalgarno fragment was removed. pT7lacOI was inserted into the vaccinia virus (strain WR) by homologous recombination (20) , creating the recombinant virus vT71acOI. The asterisk denotes the exchange of adenosine for guanosine in the native TAAATG sequence. The boxed area represents the 22-bp lacO sequence with dyad symmetry. (B) A 2.6-kbp T7genel EcoRI DNA fragment, in which an EcoRI site was engineered just downstream of the translation start site (see Materials and Methods), was inserted into the EcoRI site of the expression vector pKB3 (8) to form pPllT7genel. This insertion vector was recombined into the TK locus of vaccinia virus (strain WR) by standard techniques, creating the recombinant virus vPllT7genel. The underlined translation start site represents its native location in the context of the 11-kDa protein.
We then wished to place a synthetic lacO adjacent to a late promoter so that repressor binding would block transcription yet not severely disturb transcription in the absence of the repressor. The optimal site for placement of the synthetic lacO sequence, relative to a vaccinia virus late promoter, was previously described (13) . Positioning of lacO, a 22-bp palindrome, immediately downstream of the highly conserved TAAAT motif of late promoters satisfied these criteria. The vaccinia virus late promoter for the gene encoding the 11-kDa structural protein (P11) was used in these studies, and the hybrid promoter was referred to as PlIlacO. A set of four overlapping and complementary oligonucleotides encompassing PlllacO were annealed and inserted into the BglII-SalI sites of placIm to create placOl. The coding sequence for T7genel, excised from pTF7genel in which the Shine-Dalgarno motif was removed and a unique BglII site was inserted, was juxtaposed immediately downstream of PlllacO, and the resulting plasmid was termed pT71acOI (Fig. 2A) . It was necessary to remove the Shine-Dalgarno sequence immediately upstream of the translation start site of T7genel to permit fusion with the Pll promoter and subsequent propagation of the recombinant plasmid in E. coli. Since the Pll promoter is transcriptionally active in E. coli, presumably, the T7 RNA polymerase expressed is toxic to the cells (14a). In this configuration, the synthetic lac operator sequence was placed two bases downstream of the RNA start site of T7genel. In addition, a recombinant plasmid, termed pPllT7genel, in which T7genel was fused to the naturally occurring translation start site of Pll which overlaps the TAAAT(G) sequence motif (Fig. 2B) (Fig. 3) harvested 24 h after infection, and cytoplasmic fractions were prepared as described previously (13) . Extracts (1 and 10 ,ul) were mixed with 32P-labeled, double-stranded oligonucleotide probe and 50 mM poly(dI-dC). The probe was composed of the oligonucleotides PE7 and PE8 annealed together, and the nonoverlapping nucleotides were filled in with [a_-3P]dCTP. The sequences of these oligonucleotides were 5'-CTATGCTAGAATTGTGAGCGCTCAC AAITCTAAATAC-3' for PE7 and 5'-TCGAGTATTTAGAATTG TGAGCGCTCACAATTC-3' for PE8. In addition, various amounts of purified E. coli lac repressor protein were mixed with probe and poly(dIdC) to serve as a positive control. The samples were separated by 8% polyacrylamide gel electrophoresis and exposed to X-ray film. Arrowhead, lac repressor bound to lacO probe. ability of the HA recombinant virus to replicate in vitro (10) . To overcome a potential problem of selection and retention of target gene sequences in the HA locus, the E. coli gpt gene under control of the vaccinia P7.5 promoter was used as a dominant selectable marker (9) . Since mammalian cells and vaccinia virus cannot use xanthine for GMP synthesis when de novo purine synthesis is blocked, i.e., in the presence of MPA, vaccinia virus expression of gpt can overcome this block and allow replication to continue. The E. coli lacZ gene encoding ,B-GAL was chosen as a reporter because the assay is quantitative and there is no detectable background of 1-GAL in mammalian cells (15) . Moreover, we anticipated that induction of blue plaque formation, in the presence of inducer and the chromogenic substrate 5-bromo-4-chloro-3-indolyl-13-D-galactopyranoside (X-Gal), may also be used for screening. Therefore, an insertion vector was constructed, termed pPT71acZ, containing these genetic elements with lacZ fused to a T7 promoter (Fig. 4) . Cells infected with vT71acOI ( Fig. 2A) were transfected with pPT71acZ, and 2 days later, cell lysates were prepared and plaqued on BSC-1 monolayers in gpt selection medium. A stable recombinant virus, designated vT71acOIZ, was isolated, plaque purified three times, and grown to a high titer.
To test the inducibility of this system, BSC-1 cell monolayers were infected with 50 PFU of vT71acOIZ with or without IPTG, and plaques were stained for 13-GAL activity in the presence of X-Gal. As shown at the bottom of Fig. 4 , in the absence of IPTG, plaques displayed a faint staining infection. T7 RNA polymerase activity in cell lysates was assayed by using a DNA template containing a T7 promoter as described previously (15) .
h Expression values are given as the amount (cpm) of 32P-labeled ribonucleotide incorporated in a standard reaction as well as the amount (%) relative to the maximum activity obtained.
pattern, presumably because of the very low, yet detectable, level of T7 RNA polymerase expressed (see Table 1 ). However, plaques formed in the presence of 10 ,uM IPTG stained dark blue when IPTG was added at the time of infection, demonstrating the inducibility of this system.
Effect of IPTG on virus replication and 13-GAL expression.
Initial experiments (1) indicated that high concentrations of IPTG specifically prevented plaque formation by vT71ac-OIZ. These observations led us to investigate the effect of IPTG on the growth of vT71acOIZ. Single-step growth curves were established for the recombinant virus vT71ac-OIZ and its parent lacking the PT71acZ cassette, vT71acOI. The addition of 1 mM IPTG at the time of infection had no effect on the ability of vT71acOI to replicate over a 24-h period (data not shown), whereas it completely abrogated replication of vT7lacOIZ (Fig. 5A) , presumably because of interference of endogenous viral transcription and/or replication. In fact, replication of vT7lacOIZ was arrested when 1 mM IPTG was added at early or late times after infection, indicating a pleiotropic adverse effect on replication. We then determined the concentration of IPTG at which virus replication became compromised (Fig. SB) . As little as 25 ,uM IPTG began to inhibit virus replication, and 50 ,uM IPTG completely abolished formation of infectious virus.
To determine the concentration of IPTG that would result in minimum inhibition of virus replication yet yield the highest level of 13-GAL expression, several doses of IPTG were tested for induction. 13-GAL activity present in lysates of BSC-1 cells infected 24 h earlier with 10 PFU of vT71acOIZ per cell by using a range of 1 to 100 ,uM IPTG was measured quantitatively as described in Materials and Methods. A maximum level of expression was obtained by using 15 ,uM IPTG, which was found to have a small inhibitory effect on vT7lacOIZ replication. At this concentration of IPTG, a 5-to 10-fold induction of 13-GAL activity was observed. These results demonstrate that a high degree of T7 RNA polymerase repression was achieved. This repression could be reversed, resulting in a considerable induction of 1-GAL activity at low IPTG concentrations.
We next wished to determine whether maximum 13-GAL expression from cells infected with vT7lacOIZ could be achieved through continuous induction at the time of infection or a burst of induction at the late times after infection. These studies, in which the single inducible virus is referred to as the Vac/Op/T7 system, were performed in comparison to the previously described hybrid Vac/T7 coinfection system (12) . By using optimal conditions for each system, cells were infected with vT7lacOIZ (Vac/Op/T7) or coinfected with recombinant vaccinia viruses vTF7-3 and vTF7LZ-1 (Vac/T7) in the absence or presence of either 15 ,uM or 1 mM IPTG added early (2 h) or late (12 h) after infection.
(Recombinant virus vTF7-3 expresses T7 RNA polymerase and vTF7LZ-1 contains the PT71acZ cassette.) Cell extracts were prepared 24 h after infection and assayed for p-GAL expression by colorimetric assay. As shown in Table 2 , the highest 1-GAL activity was obtained when cells were infected at an MOI of 10 in the presence of 15 ,uM IPTG added at 2 h postinfection (100%). This activity is approximately twofold greater than that obtained for the coinfection system. Similar results were obtained when cells were infected with vT71acOIZ or coinfected by using the Vac/T7 system in the presence or absence of IPTG and 13-GAL protein was measured by immunoblot analysis (1) . On the basis of this analysis, with purified 13-GAL as a standard, we estimated that approximately 5 ,ug of 1-GAL per 106 cells was made 24 h after infection by the Vac/Op/T7 system.
DISCUSSION
We have described a unique mammalian cell expression system in which prokaryotic transcriptional and regulatory elements were used to control the expression of a foreign gene carried by an animal virus host vector. We selected bacteriophage T7 RNA polymerase for its highly specific and catalytic properties and regulatory elements from the E. coli lactose operon for their ability to block transcription over several orders of magnitude. Vaccinia virus was chosen as a desirable vector system because it has a cytoplasmic mode of replication and it encodes mRNA modification enzymes which appear necessary for the translation of T7-specific transcripts (3, 7) . In addition, vaccinia virus can replicate in a wide host range of cell types and amplifies its genome from 10,000 to 20,000 copies per cell, thereby increasing the copy number of the target gene template.
Initial attempts were made to incorporate a T7 promoter into the genome of a vaccinia virus recombinant that constitutively expressed T7 RNA polymerase. These attempts were unsuccessful, presumably because of the high catalytic properties of the polymerase, resulting in the interference with viral transcription and/or replication. Similar observations have been reported for E. coli with which even basal T7 RNA polymerase expression present in an uninduced cell can prevent, in some cases, target genes from being established in the same cell. In fact, the use of T7 lysozyme to inhibit such basal transcription was necessary to overcome this problem (4) . These observations support the finding that relatively small amounts of T7 RNA polymerase can direct most of the resources of an E. coli cell toward expression of a target gene (27, 28) . Furthermore, cells infected with a vaccinia virus recombinant expressing T7 RNA polymerase can direct 30% of total cellular RNA to be initiated from a T7 promoter (14) . Therefore, transfer of the E. coli lac operator- lac operator just downstream of a T7 promoter strongly represses transcription in E. coli, yet the usual high levels of expression are obtained after induction (4) . An interesting observation demonstrating the potency of the Vac/OpMT7 system was the ability to titrate the repression of virus replication by using increasing concentrations of IPTG. This effect could be due to the burden of RNA overproduction and/or read-through transcription into distally located viral transcription units, causing disruption of normal gene function. With regard to the latter, the T7 late terminator, TP, has been shown to terminate T7 RNA polymerase procession 80 to 90% of the time either in vitro or in vivo (5, 22) . Although Northern (RNA) blot analysis of T7-initiated transcripts from the hybrid VacfM7 system indicated that the T7 termination signal was effectively used, Si nuclease analysis suggested that read-through transcription also occurred (14) . Whether this amount of read-through impedes virus replication needs to be determined. Since TO1 is structurally similar to the rho-independent class of E. coli terminators, use of strong ribosomal terminators, such as rrnBT1, may be one approach for improving the stringency of transcription termination. The general utility of this single virus Vac/Op/17 system was demonstrated for the production of proteins at levels higher than those achieved by using the Vac/T7 coinfection system. Moreover, as optimal gene expression by using the VacFM7 system is dependent on cells being coinfected with equal MOIs of two recombinant viruses, the single-virus Vac/Op/M7 system could be used at a low MOI to establish a spreading infection. Selection of viral mutants with a more persistent or prolonged infection phenotype in vitro, with reduced ability to replicate in vivo, may offer significant advantages and is under investigation. For these reasons, the Vac/OpMT7 system may be more economical, easier to use, and less subject to variation than a coinfection system for large-scale protein production.
